We use a small number of cookies to give you the best experience of our website. If you continue to view the Positive Action site we'll assume that you are happy to receive these cookies. Find out exactly what cookies we use and how to turn them off.

Continue

HIV in the News

This page contains the most recent HIV related news from NAM aidsmap. You can read the full story by clicking on the headlines.

Healthcare providers should discuss U=U with all their HIV-positive patients

Healthcare providers should inform all patients with HIV they cannot transmit HIV to a sexual partner when their viral load is undetectable, argue the authors of  a strongly worded comment in The Lancet HIV. The authors note that despite overwhelming scientific data supporting the undetectable = untransmittable (U=U) message, significant numbers of healthcare providers do not ... full story

Mon, 18 Mar 2019

TAF: Quick-dissolve combination PrEP insert is effective against HIV infections in monkeys; intermittent solo pill less so

Two studies in monkeys of experimental pre-exposure prophylaxis (PrEP) regimens featuring the drug tenofovir alafenamide (TAF) produced differing results when presented at last week?s Conference on Retroviruses and Opportunistic Infections (CROI 2019) in Seattle. As a third study suggested, the results may partly be due to the way TAF is absorbed into cells. TAF ... full story

Wed, 13 Mar 2019

Dolutegravir-based second-line ART achieves excellent virological outcomes even in the presence of resistance to recycled NRTIs

Virological response rates were excellent among patients receiving second-line antiretroviral therapy (ART) based on dolutegravir, even when regimens included a nucleoside/nucleotide reverse transcriptase inhibitor (NRTI) to which there was pre-existing resistance, according to research presented to the Conference on Retroviruses and Opportunistic Infections (CROI 2019). The research was conducted in middle- and low-income countries and ... full story

Wed, 13 Mar 2019

Higher HIV viral load and lower CD4 count linked to liver cancer risk

People living with HIV who have a longer duration of detectable viral load and those with low CD4 cell counts have a higher likelihood of developing liver cancer in the absence of advanced fibrosis, according to a study presented at the Conference on Retroviruses and Opportunistic Infections (CROI 2019) last week, in Seattle. Since ... full story

Wed, 13 Mar 2019

Thailand?s achievements in HIV are not all widely implemented

?Thailand is progressing in the right direction to end AIDS, but needs sustained political and policy commitment with a sense of urgency for ?the last miles?,? Dr Praphan Phanuphak of the Thai Red Cross AIDS Research Center told the Conference on Retroviruses and Opportunistic Infections (CROI 2019) in Seattle, last week. The country has numerous ... full story

Tue, 12 Mar 2019

?Gentler cure? technique produces delay in viral rebound in some people taken off HIV therapy

Researchers have introduced genetic changes into human T-cells that make them virtually immune to HIV infection, and the viral load in HIV-positive people who are inoculated with these cells returns more slowly when they are taken off therapy, the recent Conference on Retroviruses and Opportunistic Infections (CROI 2019) heard. The challenge now is to ... full story

Tue, 12 Mar 2019

U=U is a human rights issue

Undetectable = Untransmittable (U=U) is a human rights issue, Dr Carrie Foote told the Conference on Retroviruses and Opportunistic Infections (CROI 2019) in Seattle last week. ?All people living with HIV have a right to accurate information about their social, sexual and reproductive health,? she said. Foote has been living with HIV since 1988, is ... full story

Tue, 12 Mar 2019

People with HIV may benefit from earlier lung cancer screening

People living with HIV, especially women, may develop lung cancer at an earlier age and with a less extensive smoking history than people in the general population, according to a study presented at the Conference on Retroviruses and Opportunistic Infections (CROI 2019) last week in Seattle. These findings suggest that lung cancer screening guidelines ... full story

Tue, 12 Mar 2019

Self-testing helps the partners of people with HIV to test, but not to link to care

Asking people living with HIV in Malawi to pass on HIV self-testing kits to their sexual partners was an effective way to encourage partners to take a test, but linkage to care was poor in a randomised study reported at the Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle last week. Dr Kathryn Dovel ... full story

Tue, 12 Mar 2019

Co-administration of dolutegravir-based treatment and short course of rifapentine/isoniazid (3HP) well tolerated in people living with HIV

Co-administration of dolutegravir-based antiretroviral therapy and short course (12 weeks) of rifapentine/isoniazid (3HP) for people living with HIV needing preventative treatment for latent tuberculosis (TB) infection was well tolerated with no adverse reactions, the Conference on Retroviruses and Opportunistic Infections (CROI 2019) heard last week in Seattle. Dr Kelly Dooley, presenting on behalf of the DOLPHIN study ... full story

Tue, 12 Mar 2019


You can read older stories on the NAM aidsmap news page.